|
|
|
[肺癌射频消融并发症及处理]
肺癌射频消融并发症
日期：2020-03-01 23:16:13
点击：179
好评：0
Chan, Victoria O.; McDermott, Shaunagh; Malone, Dermot E.; Dodd, Jonathan D. Percutaneous Radiofrequency Ablation of Lung Tumors: Evaluation of the Literature Using Evidence-based Techniques。Journal of Thoracic Imaging. 26(1):18-26, Febru...
[3cm≤大小＞3cm]
肺癌疗效比较：3cm
日期：2020-03-01 22:57:39
点击：94
好评：0
RFA - Local efficacy Median time to local tumor progression Simon CJ et al., Pulmonary Radiofrequency Ablation: Long-Term Safety and Efficacy in 153 Patients 2007, Radiology...
[肺癌消融禁忌症]
肺癌射频消融禁忌症
日期：2020-03-01 22:34:24
点击：195
好评：0
PERCUTANEOUS ABLATIONS Clinical Criteria: Exclusion Contraindications: - Pulmonary hypertension - Malignant Effusion Abbas G, et al. Surg Oncol 2009;100(8):645-50 Relative contraindications: - Poor lung function: FEV11L respiratory failure...
[肺癌射频消融原理]
射频消融的原理
日期：2020-03-01 22:20:36
点击：65
好评：0
Rational for ablation Its effective (technically, oncologically, economically, ...) Its minimally-invasive Its easy to perform and safe Its still constantly evolving (new generators, smaller applicators, computer-based treatment planning,...
[CIRSE：Guidelines]
欧洲C CIRSE 肺癌消融指南
日期：2020-03-01 22:02:44
点击：193
好评：0
Invited Submission: CIRSE Standards of Practice Guidelines Published: 21 January 2012 Standards of Practice: Guidelines for Thermal Ablation of Primary and Secondary Lung Tumors...
[研究报告标准化]
经皮肺癌热消融：研究报告的标准化
日期：2020-02-28 22:34:22
点击：158
好评：0
纳入标准是为了界定被认为最有可能从实验疗法中获益的人群，因此排除了不在临床研究方案进行治疗的可能性...
[WCIO]
世界肿瘤介入大会：关于原发肺癌的热消融
日期：2020-02-28 22:18:15
点击：121
好评：0
Thermal ablation is a safe therapeutic option to provide local control for 1 lung malignancies. Thermal ablation confers survival benefits in carefully selected patients: RF ablation with encouraging mid- and now long-term results. Studies...
[1和II期高危患者比较]
I和II期高危NSCLC治疗比较
日期：2020-02-28 22:05:24
点击：194
好评：2
RF Ablation Results: Comparative Therapies High-risk stage 1 and 2 NSCLC Modality 1-year 2-year 3-year 5-year LC DM Zemlyaketal SLR(25) 87.1% 12% 12% 3-ycancer-specific 90.6%,87.5%,90.2% 3-ycancer-free(p0.05) 60.8%,50%,45.6% RFA(12) 87.5%...
[I 期 NSCLC]
早期NSCLC治疗方式的比较
日期：2020-02-28 21:32:58
点击：86
好评：0
RF Ablation Results: Comparative Therapies M odality 5-yearsurvival StageINSCLC LocalRecurrence (mostwithin2years) Lobarresection 60-80% 能手术尽手术 6.4% Sub-lobarresection 60-70% 17.2% Image-guidedablation 27% 22.2%1 Externalbeamradiatio...
[I期 NSCLC]
I期 NSCLC 射频消融结果
日期：2020-02-28 21:23:38
点击：66
好评：0
RF Ablation Results Pulmonary RFA: Long-term safety and efficacy in 153 patients1 - Local control group (n = 132) - 71 patients with stage I NSCLC - Overall survival rates: stage I NSCLC 78% 57% 36% 27% 27% 1-year 2-year 3-year 4-year 5-ye...
RF Ablation Results: Comparative Therapies High-risk stage 1 and 2 NSCLC Modalit...
Post-ablation Care Through Discharge Post-procedural nurse and physician assessm...